Clinical Trials · NCT07640139
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Enrolling By InvitationN/ATirzepatide (Investigational)Semaglutide (Investigational)Liraglutide (Investigational)
- Phase
- N/A
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Indiana University
- Enrollment
- 125,000
- Start date
- Jan 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in subject body weight.